Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

Canada approves Axcan's Photofrin.
March 31, 2003

Guidant to acquire Biosensors' everolimus-eluting stent.
March 31, 2003

Barr's generic Adderall cleared in USA.
March 31, 2003

Endo's oxymorphone shows promise in back pain.
March 31, 2003

British Biotech merges, "more M&A to come".
March 31, 2003

ThermoGenesis closes $4.8M financing.
March 31, 2003

Ligand earns $1.5M from Lilly milestone.
March 31, 2003

Andrx takes pre-emptive measures.
March 31, 2003

B-MS restates its restatement.
March 31, 2003

Galen's Femring cleared by FDA.
March 31, 2003

Renzapride Ph IIb recruitment complete.
March 31, 2003

UCB's Keppra gives pain relief in MS.
March 31, 2003

Positive CPMP view on Roche's Fuzeon.
March 31, 2003

Ribozyme to appeal Nasdaq delisting.
March 31, 2003

US life Sciences regain prominence in venture capital arena.
March 31, 2003

Cellzome completes 30M-euro funding.
March 31, 2003

Neurochem collaborates with INSERM.
March 31, 2003

Vernalis CEO exits as losses widen in 2002.
March 31, 2003

OGS saga deepens, Celltech buys stake.
March 31, 2003

Elan shareholders OK "critical" divestment.
March 31, 2003

Michigan Blues take generic promo on road.
March 31, 2003

Together Rx plan not reaching US seniors?
March 31, 2003

Canadian drugs: first US storefront warned.
March 31, 2003

US Senate votes on Rx funds, pediatric tests.
March 31, 2003

Pfizer/pharmacy to promote Rx card.
March 31, 2003

New clinical data back up Raptiva's efficacy in psoriasis; other AAD n...
March 31, 2003

Zeltia denies any contact with B-MS.
March 31, 2003

Intercare sales leap 27%, profit up 15%.
March 31, 2003

BI breaks ground on new Austrian site.
March 31, 2003

AAHP call to FDA over Canadian imports.
March 31, 2003

PBM acts on conflict-of-interest claims.
March 31, 2003

Canadian pharmacy to open 360 US units.
March 31, 2003

Japanese govt and Osaka University fined over MMR.
March 31, 2003

Losses improve at Canada's Biomira but revenues decline.
March 31, 2003

Australia's Biota being courted by asset stripper.
March 31, 2003

GenVault raises $10M from Series A financing.
March 31, 2003

Africa "must make its own generic drugs".
March 31, 2003

New WHO International Pharmacopoiea.
March 31, 2003

Canada watchdog OKs GSK drug export ban.
March 31, 2003

Indian firm to make meningitis vaccine.
March 31, 2003

Malawi adds free TB drugs for HIV patients.
March 31, 2003

Pakistani drug imports.
March 31, 2003

Berlex launches rosacea gel in USA.
March 31, 2003

Galen gets US OK for Femring.
March 31, 2003

Fujisawa drug clears Phase II for AF.
March 31, 2003

Eon gets "no go" on generic Skelaxin.
March 31, 2003

Vectura starts Ph IIa trial of ED drug.
March 31, 2003

Prima BioMed and Medarex link up on Abs for cancer.
March 31, 2003

Pneumonia bug may be coronavirus.
March 31, 2003

Axcan launches new URSO formulation.
March 31, 2003

Zelos fundraising sets up PTH analog trial.
March 31, 2003

New Augmentin generic for Ranbaxy.
March 31, 2003

Meningitis A vaccine to enter trials in 03?
March 31, 2003

New use for Norditropin backed in EU.
March 31, 2003

Genzyme starts Pompe disease trials.
March 31, 2003

Axcan's Helicide approved in Canada.
March 31, 2003

Chiron names GSK's Howard Pien as CEO.
March 31, 2003

Baxter to acquire ML Labs' icodextrin-making facility.
March 31, 2003

Senior promotions at GlaxoSmithKline.
March 31, 2003

Servier investing $49M in Poland.
March 31, 2003

Poland Pharma Group forecasts $773M sales for 2003.
March 31, 2003

Toon Wilderbeek takes over as president of Organon International.
March 31, 2003

David Snow named CEO of Medco Health.
March 31, 2003

Darius Sulnis named chairman of Lithuania's Sanitas.
March 31, 2003

Connetics recruits Michael Miller.
March 31, 2003

BattellePharma names Leslie Williams VP, commercial development.
March 31, 2003

Acambis gets final installment from Bxter.
March 31, 2003

Chronimed to distribute Fuzeon in USA.
March 31, 2003

Antares modifies 4th-qtr and full-year figures.
March 31, 2003

Elan in $10M accord with Ingenium Pharma.
March 31, 2003

Biocompatibles to pay L55M after US law suit.
March 31, 2003

Tokyo pharma stocks - week to Mar 24.
March 31, 2003

Radiant Research buys Protocare divisions.
March 31, 2003

Japanese health care prices in February.
March 31, 2003

Japan to amend NDA priority-review process.
March 31, 2003

Page 1|2|3|4|5|6|7|8